September 2025
1. LI Y, Yuan X, Yin XF, Zheng D, et al
   Proteomics analysis and immune profiling reveal regulators of PD-L1 in oesophageal squamous cell carcinoma.
   Br J Cancer. 2025;133:448-463.
   

   >> Share

   
   
2. LAN Z, Yang Y, Li L, Wang C, et al
   Spatial omics technology potentially promotes the progress of tumor immunotherapy.
   Br J Cancer. 2025;133:421-434.
   

   >> Share

   
   
3. YANG X, Sun L, Guo J, Zheng Y, et al
   Deciphering the role of IGF2BP2 and PRMT5 in gallbladder cancer progression: insights from multi-omics analysis.
   Br J Cancer. 2025;133:486-507.
   

   >> Share

   
   June 2025
4. BARRAUD S, Vacher S, Schiffler C, Wong J, et al
   Genomic landscape of estrogen receptor-positive HER2-negative advanced breast cancer with acquired resistance to aromatase inhibitors: Identification of an ESR1 alteration-related gene signature.
   Br J Cancer. 2025 Jun 12. doi: 10.1038/s41416-025-03083.
   

   >> Share

   
   
5. HUANG C, Qiu Z, Huang H, Xiao X, et al
   Alterations in genomic features and the tumour immune microenvironment predict immunotherapy outcomes in advanced biliary tract cancer patients.
   Br J Cancer. 2025;132:1072-1082.
   

   >> Share

   
   March 2025
6. LEE HJ, Park SW, Lee JH, Chang SY, et al
   Differential cellular origins of the extracellular matrix of tumor and normal tissues according to colorectal cancer subtypes.
   Br J Cancer. 2025 Mar 3. doi: 10.1038/s41416-025-02964.
   

   >> Share

   
   December 2024
7. LEUNG EYL, Robbins HL, Zaman S, Lal N, et al
   The potential clinical utility of Whole Genome Sequencing for patients with cancer: evaluation of a regional implementation of the 100,000 Genomes Project.
   Br J Cancer. 2024;131:1805-1813.
   

   >> Share

   
   November 2024
8. TAN R, Wen M, Yang W, Zhan D, et al
   Integrated proteomics and scRNA-seq analyses of ovarian cancer reveal molecular subtype-associated cell landscapes and immunotherapy targets.
   Br J Cancer. 2024 Nov 15. doi: 10.1038/s41416-024-02894.
   

   >> Share

   
   
9. KAUFMANN M, Vaysse PM, Savage A, Kooreman LFS, et al
   Testing of rapid evaporative mass spectrometry for histological tissue classification and molecular diagnostics in a multi-site study.
   Br J Cancer. 2024;131:1298-1308.
   

   >> Share

   
   
10. TORR B, Jones C, Kavanaugh G, Hamill M, et al
    BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial.
    Br J Cancer. 2024;131:1506-1515.
    

    >> Share

    
    October 2024
11. SHEN M, Garcia-Marques F, Muruganantham A, Liu S, et al
    Identification of a 5-gene signature panel for the prediction of prostate cancer progression.
    Br J Cancer. 2024 Oct 14. doi: 10.1038/s41416-024-02854.
    

    >> Share

    
    August 2024
12. NAGELBERG AL, Sihota TS, Chuang YC, Shi R, et al
    Integrative genomics identifies SHPRH as a tumor suppressor gene in lung adenocarcinoma that regulates DNA damage response.
    Br J Cancer. 2024;131:534-550.
    

    >> Share

    
    July 2024
13. ANGERILLI V, Sabella G, Simbolo M, Lagano V, et al
    Comprehensive genomic and transcriptomic characterization of high-grade gastro-entero-pancreatic neoplasms.
    Br J Cancer. 2024;131:159-170.
    

    >> Share

    
    
14. VALOUS NA, Popp F, Zornig I, Jager D, et al
    Graph machine learning for integrated multi-omics analysis.
    Br J Cancer. 2024;131:205-211.
    

    >> Share

    
    June 2024
15. TSOULAKI O, Tischkowitz M, Antoniou AC, Musgrave H, et al
    Joint ABS-UKCGG-CanGene-CanVar consensus regarding the use of CanRisk in clinical practice.
    Br J Cancer. 2024;130:2027-2036.
    

    >> Share

    
    May 2024
16. MENG XN, Ma JF, Liu YH, Li SQ, et al
    Dynamic genomic changes in methotrexate-resistant human cancer cell lines beyond DHFR amplification suggest potential new targets for preventing drug resistance.
    Br J Cancer. 2024;130:1819-1827.
    

    >> Share

    
    April 2024
17. DHAR C, Ramachandran P, Xu G, Pickering C, et al
    Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling.
    Br J Cancer. 2024 Apr 24. doi: 10.1038/s41416-024-02644.
    

    >> Share

    
    March 2024
18. FELIU J, Gamez-Pozo A, Martinez-Perez D, Perez-Wert P, et al
    Functional proteomics of colon cancer Consensus Molecular Subtypes.
    Br J Cancer. 2024 Mar 14. doi: 10.1038/s41416-024-02650.
    

    >> Share

    
    February 2024
19. PRETE AA, Angerilli V, Bergamo F, Vettore V, et al
    HER2 expression and genOmic characterization of rESected brain metastases from colorectal cancer: the HEROES study.
    Br J Cancer. 2024 Feb 12. doi: 10.1038/s41416-023-02569.
    

    >> Share

    
    January 2024
20. WANG Y, He M, He T, Ouyang X, et al
    Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers.
    Br J Cancer. 2024 Jan 22. doi: 10.1038/s41416-023-02555.
    

    >> Share

    
    
21. HALLAL SM, Tuzesi A, Sida LA, Xian E, et al
    Glioblastoma biomarkers in urinary extracellular vesicles reveal the potential for a 'liquid gold' biopsy.
    Br J Cancer. 2024 Jan 11. doi: 10.1038/s41416-023-02548.
    

    >> Share

    
    December 2023
22. GRASSMANN F, Malarstig A, Dahl L, Bendes A, et al
    The impact of circulating protein levels identified by affinity proteomics on short-term, overall breast cancer risk.
    Br J Cancer. 2023 Dec 22. doi: 10.1038/s41416-023-02541.
    

    >> Share

    
    September 2023
23. PAYNE K, Brooks J, Batis N, Khan N, et al
    Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping.
    Br J Cancer. 2023 Sep 21. doi: 10.1038/s41416-023-02428.
    

    >> Share

    
    
24. YANG Y, Xu S, Jia G, Yuan F, et al
    Integrating genomics and proteomics data to identify candidate plasma biomarkers for lung cancer risk among European descendants.
    Br J Cancer. 2023 Sep 7. doi: 10.1038/s41416-023-02419.
    

    >> Share

    
    
25. LIU Z, Duan T, Zhang Y, Weng S, et al
    Radiogenomics: a key component of precision cancer medicine.
    Br J Cancer. 2023;129:741-753.
    

    >> Share

    
    August 2023
26. VAN MOURIK A, Tonkin-Hill G, O'Farrell J, Waller S, et al
    Six-year experience of Australia's first dedicated cancer of unknown primary clinic.
    Br J Cancer. 2023;129:301-308.
    

    >> Share

    
    July 2023
27. LEE JE, Kim KT, Shin SJ, Cheong JH, et al
    Genomic and evolutionary characteristics of metastatic gastric cancer by routes.
    Br J Cancer. 2023 Jul 8. doi: 10.1038/s41416-023-02338.
    

    >> Share

    
    June 2023
28. XU L, Su H, Zhao S, Si H, et al
    Development of the semi-dry dot-blot method for intraoperative detecting micropapillary component in lung adenocarcinoma based on proteomics analysis.
    Br J Cancer. 2023;128:2116-2125.
    

    >> Share

    
    
29. KITAGAWA A, Osawa T, Noda M, Kobayashi Y, et al
    Convergent genomic diversity and novel BCAA metabolism in intrahepatic cholangiocarcinoma.
    Br J Cancer. 2023;128:2206-2217.
    

    >> Share

    
    May 2023
30. RASMUSSEN SV, Wozniak A, Lathara M, Goldenberg JM, et al
    Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.
    Br J Cancer. 2023;128:1941-1954.
    

    >> Share

    
    April 2023
31. ROSSWOG C, Fassunke J, Ernst A, Schomig-Markiefka B, et al
    Genomic ALK alterations in primary and relapsed neuroblastoma.
    Br J Cancer. 2023;128:1559-1571.
    

    >> Share

    
    March 2023
32. CIFUENTES GA, Santiago A, Mendez Blanco L, Fueyo M, et al
    Clinical utility of liquid biopsy and integrative genomic profiling in early-stage and oligometastatic cancer patients treated with radiotherapy.
    Br J Cancer. 2023;128:857-876.
    

    >> Share

    
    February 2023
33. NJOKU K, Pierce A, Geary B, Campbell AE, et al
    Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women.
    Br J Cancer. 2023 Feb 17. doi: 10.1038/s41416-022-02139.
    

    >> Share

    
    
34. CHEN G, Zhang J, Fu Q, Taly V, et al
    Integrative analysis of multi-omics data for liquid biopsy.
    Br J Cancer. 2023;128:505-518.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share